Dr Darren Feldman

Dr. Feldman is an Associate Attending Physician on the Genitourinary Oncology Service and Bone Marrow Transplant (BMT) Service within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC) and Associate Professor of Medicine at Weill Medical College of Cornell University, both in New York City, NY.

Dr. Feldman’s research focuses on understanding the biology and improving the treatment for patients with germ cell tumors (GCT) and kidney tumors, and the mechanism and management of late toxicities resulting from GCT treatment, particularly effects on the cardiovascular system. At MSKCC, he is the Section Head for GCT within the Genitourinary Oncology Service, overseeing the GCT medical oncology research program. He has led and is currently leading national and international trials in the treatment of GCT and kidney cancer and has presented his research at meetings around the world. He also served as the Chair of Quality Assurance for the Department of Medicine at MSKCC from 2018 to 2024.